Who has invested in Araris Biotech?

Innosuisse are named among the investors backing Araris Biotech.

Araris Biotech Funding: $40M Raised, Seed (2023)

Araris Biotech funding overview

Araris Biotech is based in Zurich, Switzerland. Araris Biotech has raised $40M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Seed announced in January 2023. The round record for Araris Biotech runs through 2023; nothing later has been disclosed. Investors on record include Innosuisse.

Araris Biotech at a glance

Total raised: $40M
Latest round: Seed
Latest round date: January 2023
Headquarters: Zurich, Switzerland
Notable investors: Innosuisse

Frequently asked about Araris Biotech funding

How much has Araris Biotech raised?: Araris Biotech has raised $40M in total disclosed funding across the rounds on record.
Who has invested in Araris Biotech?: Innosuisse are named among the investors backing Araris Biotech.
What was the latest Araris Biotech funding round?: The most recent disclosed round is a Seed, announced in January 2023.
Where is Araris Biotech based?: Araris Biotech is based in Zurich, Switzerland.
When did Araris Biotech last raise?: The last disclosed Araris Biotech round closed in January 2023 at Seed.

Round data for Araris Biotech is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Zurich and backer lists below.

Araris Biotech Funding: $40M Raised, Seed (2023)

Araris Biotech funding overview

Araris Biotech at a glance

Frequently asked about Araris Biotech funding

Companies related to Araris Biotech (19)

Browse related funding lists (3)